berotek has been researched along with Shock, Cardiogenic in 1 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Irmer, M | 1 |
| Wollschläger, H | 1 |
| Just, H | 1 |
1 other study available for berotek and Shock, Cardiogenic
| Article | Year |
|---|---|
[Treatment of severe congestive heart failure with the beta-agonist fenoterol (author's transl)].
Topics: Adrenergic beta-Agonists; Adult; Aged; Cardiac Output, Low; Coronary Disease; Ethanolamines; Female; | 1981 |